Systemic metabolic changes linked to each UGT KO were significantly associated, positively and negatively, with various health conditions including obesity, diabetes, hypertension, osteoporosis and arthritis, extending the potential impact of UGT deletions on health and disease. Here, SLC35A2 is linked to obesity due to melanocortin 4 receptor deficiency.